---
schema_version: "secwatch.filing_event.v1"
accession: "0001013762-21-000153"
form_type: "8-K"
ticker: "CRMD"
cik: "0001410098"
company_name: "CorMedix Inc."
filed_at: "2021-10-05T23:59:59+00:00"
generated_at: "2026-06-28T22:54:12.257453+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CorMedix CEO and EVP retire; CFO Matthew David named interim CEO

## Summary
- Khoso Baluch retired as CEO effective Oct 4, 2021, and resigned from the Board.
- John Armstrong retired as EVP, Technical Operations, effective same date.
- CFO Matthew David appointed interim CEO; search for permanent CEO initiated with executive search firm.
- Both executives received severance per employment agreements; vested stock options exercisable up to 3 years post-retirement.

## SEC filing metadata
- accession: 0001013762-21-000153
- form_type: 8-K
- ticker: CRMD
- cik: 0001410098
- company_name: CorMedix Inc.
- filed_at: 2021-10-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1410098/000101376221000153/0001013762-21-000153-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1410098/000101376221000153/ea148384-8k_cormedix.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001013762-21-000153
- JSON: https://secwatch.observer/filing/0001013762-21-000153.json
- Plain text: https://secwatch.observer/filing/0001013762-21-000153.txt

## Key facts
- Executive change
  Matthew David was appointed as Interim Chief Executive Officer at CorMedix Inc..
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: Matthew David, M.D., the Company’s current Chief Financial Officer, will serve as interim Chief Executive Officer, effective immediately, until a new Chief Executive Officer is appointed.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1410098/000101376221000153/0001013762-21-000153-index.htm
- Executive change
  John L. Armstrong, Jr. retired as Executive Vice President, Technical Operations at CorMedix Inc..
  - Action: retired
  - Role: Executive Vice President, Technical Operations
  source text: On October 4, 2021, the Company and John L. Armstrong, Jr. came to a mutual agreement pursuant to which Mr. Armstrong will retire from his position as the Company’s Executive Vice President, Technical Operations, effective October 4, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1410098/000101376221000153/0001013762-21-000153-index.htm
- Executive change
  Khoso Baluch retired as Chief Executive Officer at CorMedix Inc..
  - Action: retired
  - Role: Chief Executive Officer
  source text: On October 1, 2021, the Company and Khoso Baluch came to a mutual agreement pursuant to which Mr. Baluch will retire from his position as the Company’s Chief Executive Officer, effective October 4, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1410098/000101376221000153/0001013762-21-000153-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.